ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016
The purpose of the study was to analyze infectious complications caused by multi-drug-resistant organisms depending on anticancer therapy.Material and Methods. A total of 229 cancer patients with infectious complications of cancer therapy were included into the study.Results. Lung cancer was the mos...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2019-09-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/1140 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839579543235461120 |
|---|---|
| author | V. V. Aginova N. V. Dmitrieva I. N. Petukhova Z. V. Grigorievskaya N. S. Bagirova I. V. Tereshchenko S. A. Dyakova T. A. Kalinchuk A. I. Dmitrieva V. D. Vinnikova |
| author_facet | V. V. Aginova N. V. Dmitrieva I. N. Petukhova Z. V. Grigorievskaya N. S. Bagirova I. V. Tereshchenko S. A. Dyakova T. A. Kalinchuk A. I. Dmitrieva V. D. Vinnikova |
| author_sort | V. V. Aginova |
| collection | DOAJ |
| description | The purpose of the study was to analyze infectious complications caused by multi-drug-resistant organisms depending on anticancer therapy.Material and Methods. A total of 229 cancer patients with infectious complications of cancer therapy were included into the study.Results. Lung cancer was the most predominant cancer (26.6 %) followed by gastric cancer (25.3 %) and esophageal cancer (14.4 %). Infectious complications occurring after surgery were observed in 83.4 % of the patients. Infectious complications caused by Acinetobacter baumannii were the most common (40.6 %), followed by Klebsiella pneumoniae (28.5 %), Pseudomonas aeruginosa (19.5 %), Staphylococcus spp. (9.4 %), and Enterococcus spp. (1.8 %).Conclusion. Infectious complications occurred more frequently in postoperative cancer patients (p<0.02), and the ESKAPE group pathogens were the leading cause of these infections. |
| format | Article |
| id | doaj-art-3dcb64f1881f459ead7a39ff3db0f47c |
| institution | Matheson Library |
| issn | 1814-4861 2312-3168 |
| language | Russian |
| publishDate | 2019-09-01 |
| publisher | Russian Academy of Sciences, Tomsk National Research Medical Center |
| record_format | Article |
| series | Сибирский онкологический журнал |
| spelling | doaj-art-3dcb64f1881f459ead7a39ff3db0f47c2025-08-04T10:33:39ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682019-09-01184434910.21294/1814-4861-2019-18-4-43-49656ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016V. V. Aginova0N. V. Dmitrieva1I. N. Petukhova2Z. V. Grigorievskaya3N. S. Bagirova4I. V. Tereshchenko5S. A. Dyakova6T. A. Kalinchuk7A. I. Dmitrieva8V. D. Vinnikova9N.N. Blokhin National Medical Research Center of Oncology Medical College № 1N.N. Blokhin National Medical Research Center of OncologyN.N. Blokhin National Medical Research Center of OncologyN.N. Blokhin National Medical Research Center of OncologyN.N. Blokhin National Medical Research Center of OncologyN.N. Blokhin National Medical Research Center of OncologyN.N. Blokhin National Medical Research Center of OncologyN.N. Blokhin National Medical Research Center of OncologyN.N. Blokhin National Medical Research Center of OncologyEvdokimov Moscow State University of Medicine and DentistryThe purpose of the study was to analyze infectious complications caused by multi-drug-resistant organisms depending on anticancer therapy.Material and Methods. A total of 229 cancer patients with infectious complications of cancer therapy were included into the study.Results. Lung cancer was the most predominant cancer (26.6 %) followed by gastric cancer (25.3 %) and esophageal cancer (14.4 %). Infectious complications occurring after surgery were observed in 83.4 % of the patients. Infectious complications caused by Acinetobacter baumannii were the most common (40.6 %), followed by Klebsiella pneumoniae (28.5 %), Pseudomonas aeruginosa (19.5 %), Staphylococcus spp. (9.4 %), and Enterococcus spp. (1.8 %).Conclusion. Infectious complications occurred more frequently in postoperative cancer patients (p<0.02), and the ESKAPE group pathogens were the leading cause of these infections.https://www.siboncoj.ru/jour/article/view/1140postoperative infectious complicationsmulti-drug-resistant organismsthoracic and abdominal tumorsantibacterial drugsimmune system |
| spellingShingle | V. V. Aginova N. V. Dmitrieva I. N. Petukhova Z. V. Grigorievskaya N. S. Bagirova I. V. Tereshchenko S. A. Dyakova T. A. Kalinchuk A. I. Dmitrieva V. D. Vinnikova ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016 Сибирский онкологический журнал postoperative infectious complications multi-drug-resistant organisms thoracic and abdominal tumors antibacterial drugs immune system |
| title | ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016 |
| title_full | ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016 |
| title_fullStr | ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016 |
| title_full_unstemmed | ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016 |
| title_short | ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016 |
| title_sort | analysis of infectious complications in cancer patients during 2014 2016 |
| topic | postoperative infectious complications multi-drug-resistant organisms thoracic and abdominal tumors antibacterial drugs immune system |
| url | https://www.siboncoj.ru/jour/article/view/1140 |
| work_keys_str_mv | AT vvaginova analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT nvdmitrieva analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT inpetukhova analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT zvgrigorievskaya analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT nsbagirova analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT ivtereshchenko analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT sadyakova analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT takalinchuk analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT aidmitrieva analysisofinfectiouscomplicationsincancerpatientsduring20142016 AT vdvinnikova analysisofinfectiouscomplicationsincancerpatientsduring20142016 |